(CGC) Canopy Growth - Ratings and Ratios
Cannabis, Vaporizers, Edibles, Oils, Joints
CGC EPS (Earnings per Share)
CGC Revenue
Description: CGC Canopy Growth
Canopy Growth Corporation is a leading cannabis and hemp-based products company with a diverse portfolio of brands and products. The company operates through three main segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel. Its product lineup includes dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles, and vaporizer devices, sold under various brands such as Tweed, 7ACRES, DOJA, and Storz & Bickel, among others.
The companys strategic expansion into international markets, particularly in Germany, has positioned it for growth in the global cannabis industry. Canopy Growth has also made significant investments in its production capabilities, allowing it to meet increasing demand for its products. The companys brand portfolio, which includes Martha Stewart and Wana, is well-established and continues to drive sales.
Analyzing the
Considering the
Forecasting CGCs future performance, a combination of technical and fundamental analysis suggests that the stock may continue to experience volatility. The recent positive trend indicated by SMA20 and SMA50 may continue if the company can demonstrate improved profitability or significant growth in its international markets. However, the long-term downtrend and high volatility must be carefully monitored. A potential target price could be around $2.50, based on a potential retracement to its previous support levels, but this would require a significant improvement in the companys financials and overall market conditions.
Additional Sources for CGC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CGC Stock Overview
Market Cap in USD | 261m |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
GiC Sub-Industry | Pharmaceuticals |
IPO / Inception | 2014-04-04 |
CGC Stock Ratings
Growth Rating | -92.4 |
Fundamental | -68.8 |
Dividend Rating | 0.0 |
Rel. Strength | -79.4 |
Analysts | 2.5 of 5 |
Fair Price Momentum | 0.42 USD |
Fair Price DCF | - |
CGC Dividends
Currently no dividends paidCGC Growth Ratios
Growth Correlation 3m | 20.3% |
Growth Correlation 12m | -91.7% |
Growth Correlation 5y | -95.4% |
CAGR 5y | -62.90% |
CAGR/Max DD 5y | -0.63 |
Sharpe Ratio 12m | -1.94 |
Alpha | -95.49 |
Beta | 1.228 |
Volatility | 96.16% |
Current Volume | 13633.8k |
Average Volume 20d | 8440.1k |
Stop Loss | 1.1 (-10.6%) |
As of July 09, 2025, the stock is trading at USD 1.23 with a total of 13,633,761 shares traded.
Over the past week, the price has changed by +8.85%, over one month by -24.07%, over three months by +48.51% and over the past year by -80.35%.
No, based on ValueRay´s Fundamental Analyses, Canopy Growth (NASDAQ:CGC) is currently (July 2025) a stock to sell. It has a ValueRay Fundamental Rating of -68.77 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CGC is around 0.42 USD . This means that CGC is currently overvalued and has a potential downside of -65.85%.
Canopy Growth has received a consensus analysts rating of 2.50. Therefor, it is recommend to sell CGC.
- Strong Buy: 0
- Buy: 2
- Hold: 4
- Sell: 1
- Strong Sell: 3
According to our own proprietary Forecast Model, CGC Canopy Growth will be worth about 0.5 in July 2026. The stock is currently trading at 1.23. This means that the stock has a potential downside of -60.16%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 2.3 | 87.8% |
Analysts Target Price | 2.3 | 85.4% |
ValueRay Target Price | 0.5 | -60.2% |